Central serotonergic and adrenergic/imidazoline inhibitory mechanisms on sodium and water intake

Recent studies have shown the existence of two important inhibitory mechanisms for the control of NaCl and water intake: one mechanism involves serotonin in the lateral parabrachial nucleus (LPBN) and the other depends on α 2-adrenergic/imidazoline receptors probably in the forebrain areas. In the p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research 2002-11, Vol.956 (1), p.103-109
Hauptverfasser: Oliveira Margatho, Lisandra, Pereira Barbosa, Silas, Antonio De Luca, Laurival, Vanderlei Menani, José
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 109
container_issue 1
container_start_page 103
container_title Brain research
container_volume 956
creator Oliveira Margatho, Lisandra
Pereira Barbosa, Silas
Antonio De Luca, Laurival
Vanderlei Menani, José
description Recent studies have shown the existence of two important inhibitory mechanisms for the control of NaCl and water intake: one mechanism involves serotonin in the lateral parabrachial nucleus (LPBN) and the other depends on α 2-adrenergic/imidazoline receptors probably in the forebrain areas. In the present study we investigated if α 2-adrenergic/imidazoline and serotonergic inhibitory mechanisms interact to control NaCl and water intake. Male Holtzman rats with cannulas implanted simultaneously into the lateral ventricle (LV) and bilaterally into the LPBN were used. The ingestion of 0.3 M NaCl and water was induced by treatment with the diuretic furosemide (10 mg/kg of body weight)+the angiotensin converting enzyme inhibitor captopril (5 mg/kg) injected subcutaneously 1 h before the access of rats to water and 0.3 M NaCl. Intracerebroventricular (i.c.v.) injection of the α 2-adrenergic/imidazoline agonist clonidine (20 nmol/1 μl) almost abolished water (1.6±1.2, vs. vehicle: 7.5±2.2 ml/2 h) and 0.3 M NaCl intake (0.5±0.3, vs. vehicle: 2.2±0.8 ml/2 h). Similar effects were produced by bilateral injections of the 5HT 2a/2c serotonergic agonist 2,5-dimetoxy-4-iodoamphetamine (DOI, 5 μg/0.2 μl each site) into the LPBN on water (3.6±0.9 ml/2 h) and 0.3 M NaCl intake (0.4±0.2 ml/2 h). Injection of the α 2-adrenergic/imidazoline antagonist idazoxan (320 nmol) i.c.v. completely blocked the effects of clonidine on water (8.4±1.5 ml/2 h) and NaCl intake (4.0±1.2 ml/2 h), but did not change the effects of LPBN injections of DOI on water (4.2±1.0 ml/2 h) and NaCl intake (0.7±0.2 ml/2 h). Bilateral injections of methysergide (4 μg/0.2 μl each site) into the LPBN increased 0.3 M NaCl intake (6.4±1.9 ml/2 h), not water intake. The inhibitory effect of i.c.v. clonidine on water and 0.3 M NaCl was still present after injections of methysergide into the LPBN (1.5±0.8 and 1.7±1.4 ml/2 h, respectively). The results show that the inhibitory effects of the activation of α 2-adrenergic/imidazoline receptors in the forebrain are still present after blockade of the LPBN serotonergic mechanisms and vice versa for the activation of serotonergic mechanisms of the LPBN. Therefore, each system may act independently to inhibit NaCl and water intake.
doi_str_mv 10.1016/S0006-8993(02)03486-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72669044</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006899302034868</els_id><sourcerecordid>18616028</sourcerecordid><originalsourceid>FETCH-LOGICAL-c488t-58980005c5f57ec23259483d136e342cac533352f11a374ba55696a9145258de3</originalsourceid><addsrcrecordid>eNqFkUtvFDEQhK0IlGwCPyHRXIjCYYjfY5-iaMVLisQBOJteuydxmLGDPQsKv57Zh8gxp1ZJX3W3qgg5ZfQdo0xffqWU6tZYKy4of0uFNLM6IAtmOt5qLukLsviPHJHjWu9nKYSlh-SIcck1VXxBfiwxTQWGpmLJU05YbqNvIIUGQsGdvIxjDPA3DzFhE9NdXMUpl8dmRH8HKdaxNjk1NYe4HrfWPzBhmckJfuIr8rKHoeLr_Twh3z-8_7b81N58-fh5eX3TemnM1Cpjzfyf8qpXHXouuLLSiMCERiG5B6-EEIr3jIHo5AqU0laDZVJxZQKKE3K-2_tQ8q811smNsXocBkiY19V1XGtLpXwWZEYzTbmZQbUDfcm1FuzdQ4kjlEfHqNt04LYduE3AjnK37cBtfGf7A-vViOHJtQ99Bt7sAagehr5A8rE-cZJS22k1c1c7DufcfkcsrvqIyWOIBf3kQo7PvPIPyiKi2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18616028</pqid></control><display><type>article</type><title>Central serotonergic and adrenergic/imidazoline inhibitory mechanisms on sodium and water intake</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Oliveira Margatho, Lisandra ; Pereira Barbosa, Silas ; Antonio De Luca, Laurival ; Vanderlei Menani, José</creator><creatorcontrib>Oliveira Margatho, Lisandra ; Pereira Barbosa, Silas ; Antonio De Luca, Laurival ; Vanderlei Menani, José</creatorcontrib><description>Recent studies have shown the existence of two important inhibitory mechanisms for the control of NaCl and water intake: one mechanism involves serotonin in the lateral parabrachial nucleus (LPBN) and the other depends on α 2-adrenergic/imidazoline receptors probably in the forebrain areas. In the present study we investigated if α 2-adrenergic/imidazoline and serotonergic inhibitory mechanisms interact to control NaCl and water intake. Male Holtzman rats with cannulas implanted simultaneously into the lateral ventricle (LV) and bilaterally into the LPBN were used. The ingestion of 0.3 M NaCl and water was induced by treatment with the diuretic furosemide (10 mg/kg of body weight)+the angiotensin converting enzyme inhibitor captopril (5 mg/kg) injected subcutaneously 1 h before the access of rats to water and 0.3 M NaCl. Intracerebroventricular (i.c.v.) injection of the α 2-adrenergic/imidazoline agonist clonidine (20 nmol/1 μl) almost abolished water (1.6±1.2, vs. vehicle: 7.5±2.2 ml/2 h) and 0.3 M NaCl intake (0.5±0.3, vs. vehicle: 2.2±0.8 ml/2 h). Similar effects were produced by bilateral injections of the 5HT 2a/2c serotonergic agonist 2,5-dimetoxy-4-iodoamphetamine (DOI, 5 μg/0.2 μl each site) into the LPBN on water (3.6±0.9 ml/2 h) and 0.3 M NaCl intake (0.4±0.2 ml/2 h). Injection of the α 2-adrenergic/imidazoline antagonist idazoxan (320 nmol) i.c.v. completely blocked the effects of clonidine on water (8.4±1.5 ml/2 h) and NaCl intake (4.0±1.2 ml/2 h), but did not change the effects of LPBN injections of DOI on water (4.2±1.0 ml/2 h) and NaCl intake (0.7±0.2 ml/2 h). Bilateral injections of methysergide (4 μg/0.2 μl each site) into the LPBN increased 0.3 M NaCl intake (6.4±1.9 ml/2 h), not water intake. The inhibitory effect of i.c.v. clonidine on water and 0.3 M NaCl was still present after injections of methysergide into the LPBN (1.5±0.8 and 1.7±1.4 ml/2 h, respectively). The results show that the inhibitory effects of the activation of α 2-adrenergic/imidazoline receptors in the forebrain are still present after blockade of the LPBN serotonergic mechanisms and vice versa for the activation of serotonergic mechanisms of the LPBN. Therefore, each system may act independently to inhibit NaCl and water intake.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/S0006-8993(02)03486-8</identifier><identifier>PMID: 12426052</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject><![CDATA[Amphetamines - administration & dosage ; Amphetamines - pharmacology ; Angiotensin II ; Angiotensin-Converting Enzyme Inhibitors - pharmacology ; Animals ; Biological and medical sciences ; Captopril - pharmacology ; Cerebellar Nuclei - drug effects ; Cerebellar Nuclei - physiology ; Clonidine ; Clonidine - administration & dosage ; Clonidine - pharmacology ; Diuretics - pharmacology ; Drinking - drug effects ; Drinking - physiology ; Drinking Behavior - drug effects ; Drinking Behavior - physiology ; Feeding. Feeding behavior ; Fundamental and applied biological sciences. Psychology ; Furosemide - pharmacology ; Idazoxan - administration & dosage ; Idazoxan - pharmacology ; Imidazoline Receptors ; Injections, Intraventricular ; Male ; Methysergide - administration & dosage ; Methysergide - pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptors, Drug - physiology ; Receptors, Serotonin - physiology ; Serotonin ; Serotonin Antagonists - administration & dosage ; Serotonin Antagonists - pharmacology ; Serotonin Receptor Agonists - administration & dosage ; Serotonin Receptor Agonists - pharmacology ; Sodium appetite ; Sodium Chloride, Dietary ; Vertebrates: anatomy and physiology, studies on body, several organs or systems ; α 2-Adrenergic receptor]]></subject><ispartof>Brain research, 2002-11, Vol.956 (1), p.103-109</ispartof><rights>2002 Elsevier Science B.V.</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c488t-58980005c5f57ec23259483d136e342cac533352f11a374ba55696a9145258de3</citedby><cites>FETCH-LOGICAL-c488t-58980005c5f57ec23259483d136e342cac533352f11a374ba55696a9145258de3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0006-8993(02)03486-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14009765$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12426052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oliveira Margatho, Lisandra</creatorcontrib><creatorcontrib>Pereira Barbosa, Silas</creatorcontrib><creatorcontrib>Antonio De Luca, Laurival</creatorcontrib><creatorcontrib>Vanderlei Menani, José</creatorcontrib><title>Central serotonergic and adrenergic/imidazoline inhibitory mechanisms on sodium and water intake</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Recent studies have shown the existence of two important inhibitory mechanisms for the control of NaCl and water intake: one mechanism involves serotonin in the lateral parabrachial nucleus (LPBN) and the other depends on α 2-adrenergic/imidazoline receptors probably in the forebrain areas. In the present study we investigated if α 2-adrenergic/imidazoline and serotonergic inhibitory mechanisms interact to control NaCl and water intake. Male Holtzman rats with cannulas implanted simultaneously into the lateral ventricle (LV) and bilaterally into the LPBN were used. The ingestion of 0.3 M NaCl and water was induced by treatment with the diuretic furosemide (10 mg/kg of body weight)+the angiotensin converting enzyme inhibitor captopril (5 mg/kg) injected subcutaneously 1 h before the access of rats to water and 0.3 M NaCl. Intracerebroventricular (i.c.v.) injection of the α 2-adrenergic/imidazoline agonist clonidine (20 nmol/1 μl) almost abolished water (1.6±1.2, vs. vehicle: 7.5±2.2 ml/2 h) and 0.3 M NaCl intake (0.5±0.3, vs. vehicle: 2.2±0.8 ml/2 h). Similar effects were produced by bilateral injections of the 5HT 2a/2c serotonergic agonist 2,5-dimetoxy-4-iodoamphetamine (DOI, 5 μg/0.2 μl each site) into the LPBN on water (3.6±0.9 ml/2 h) and 0.3 M NaCl intake (0.4±0.2 ml/2 h). Injection of the α 2-adrenergic/imidazoline antagonist idazoxan (320 nmol) i.c.v. completely blocked the effects of clonidine on water (8.4±1.5 ml/2 h) and NaCl intake (4.0±1.2 ml/2 h), but did not change the effects of LPBN injections of DOI on water (4.2±1.0 ml/2 h) and NaCl intake (0.7±0.2 ml/2 h). Bilateral injections of methysergide (4 μg/0.2 μl each site) into the LPBN increased 0.3 M NaCl intake (6.4±1.9 ml/2 h), not water intake. The inhibitory effect of i.c.v. clonidine on water and 0.3 M NaCl was still present after injections of methysergide into the LPBN (1.5±0.8 and 1.7±1.4 ml/2 h, respectively). The results show that the inhibitory effects of the activation of α 2-adrenergic/imidazoline receptors in the forebrain are still present after blockade of the LPBN serotonergic mechanisms and vice versa for the activation of serotonergic mechanisms of the LPBN. Therefore, each system may act independently to inhibit NaCl and water intake.</description><subject>Amphetamines - administration &amp; dosage</subject><subject>Amphetamines - pharmacology</subject><subject>Angiotensin II</subject><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Captopril - pharmacology</subject><subject>Cerebellar Nuclei - drug effects</subject><subject>Cerebellar Nuclei - physiology</subject><subject>Clonidine</subject><subject>Clonidine - administration &amp; dosage</subject><subject>Clonidine - pharmacology</subject><subject>Diuretics - pharmacology</subject><subject>Drinking - drug effects</subject><subject>Drinking - physiology</subject><subject>Drinking Behavior - drug effects</subject><subject>Drinking Behavior - physiology</subject><subject>Feeding. Feeding behavior</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Furosemide - pharmacology</subject><subject>Idazoxan - administration &amp; dosage</subject><subject>Idazoxan - pharmacology</subject><subject>Imidazoline Receptors</subject><subject>Injections, Intraventricular</subject><subject>Male</subject><subject>Methysergide - administration &amp; dosage</subject><subject>Methysergide - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Drug - physiology</subject><subject>Receptors, Serotonin - physiology</subject><subject>Serotonin</subject><subject>Serotonin Antagonists - administration &amp; dosage</subject><subject>Serotonin Antagonists - pharmacology</subject><subject>Serotonin Receptor Agonists - administration &amp; dosage</subject><subject>Serotonin Receptor Agonists - pharmacology</subject><subject>Sodium appetite</subject><subject>Sodium Chloride, Dietary</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><subject>α 2-Adrenergic receptor</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtvFDEQhK0IlGwCPyHRXIjCYYjfY5-iaMVLisQBOJteuydxmLGDPQsKv57Zh8gxp1ZJX3W3qgg5ZfQdo0xffqWU6tZYKy4of0uFNLM6IAtmOt5qLukLsviPHJHjWu9nKYSlh-SIcck1VXxBfiwxTQWGpmLJU05YbqNvIIUGQsGdvIxjDPA3DzFhE9NdXMUpl8dmRH8HKdaxNjk1NYe4HrfWPzBhmckJfuIr8rKHoeLr_Twh3z-8_7b81N58-fh5eX3TemnM1Cpjzfyf8qpXHXouuLLSiMCERiG5B6-EEIr3jIHo5AqU0laDZVJxZQKKE3K-2_tQ8q811smNsXocBkiY19V1XGtLpXwWZEYzTbmZQbUDfcm1FuzdQ4kjlEfHqNt04LYduE3AjnK37cBtfGf7A-vViOHJtQ99Bt7sAagehr5A8rE-cZJS22k1c1c7DufcfkcsrvqIyWOIBf3kQo7PvPIPyiKi2A</recordid><startdate>20021122</startdate><enddate>20021122</enddate><creator>Oliveira Margatho, Lisandra</creator><creator>Pereira Barbosa, Silas</creator><creator>Antonio De Luca, Laurival</creator><creator>Vanderlei Menani, José</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20021122</creationdate><title>Central serotonergic and adrenergic/imidazoline inhibitory mechanisms on sodium and water intake</title><author>Oliveira Margatho, Lisandra ; Pereira Barbosa, Silas ; Antonio De Luca, Laurival ; Vanderlei Menani, José</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c488t-58980005c5f57ec23259483d136e342cac533352f11a374ba55696a9145258de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Amphetamines - administration &amp; dosage</topic><topic>Amphetamines - pharmacology</topic><topic>Angiotensin II</topic><topic>Angiotensin-Converting Enzyme Inhibitors - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Captopril - pharmacology</topic><topic>Cerebellar Nuclei - drug effects</topic><topic>Cerebellar Nuclei - physiology</topic><topic>Clonidine</topic><topic>Clonidine - administration &amp; dosage</topic><topic>Clonidine - pharmacology</topic><topic>Diuretics - pharmacology</topic><topic>Drinking - drug effects</topic><topic>Drinking - physiology</topic><topic>Drinking Behavior - drug effects</topic><topic>Drinking Behavior - physiology</topic><topic>Feeding. Feeding behavior</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Furosemide - pharmacology</topic><topic>Idazoxan - administration &amp; dosage</topic><topic>Idazoxan - pharmacology</topic><topic>Imidazoline Receptors</topic><topic>Injections, Intraventricular</topic><topic>Male</topic><topic>Methysergide - administration &amp; dosage</topic><topic>Methysergide - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Drug - physiology</topic><topic>Receptors, Serotonin - physiology</topic><topic>Serotonin</topic><topic>Serotonin Antagonists - administration &amp; dosage</topic><topic>Serotonin Antagonists - pharmacology</topic><topic>Serotonin Receptor Agonists - administration &amp; dosage</topic><topic>Serotonin Receptor Agonists - pharmacology</topic><topic>Sodium appetite</topic><topic>Sodium Chloride, Dietary</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><topic>α 2-Adrenergic receptor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oliveira Margatho, Lisandra</creatorcontrib><creatorcontrib>Pereira Barbosa, Silas</creatorcontrib><creatorcontrib>Antonio De Luca, Laurival</creatorcontrib><creatorcontrib>Vanderlei Menani, José</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oliveira Margatho, Lisandra</au><au>Pereira Barbosa, Silas</au><au>Antonio De Luca, Laurival</au><au>Vanderlei Menani, José</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Central serotonergic and adrenergic/imidazoline inhibitory mechanisms on sodium and water intake</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>2002-11-22</date><risdate>2002</risdate><volume>956</volume><issue>1</issue><spage>103</spage><epage>109</epage><pages>103-109</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Recent studies have shown the existence of two important inhibitory mechanisms for the control of NaCl and water intake: one mechanism involves serotonin in the lateral parabrachial nucleus (LPBN) and the other depends on α 2-adrenergic/imidazoline receptors probably in the forebrain areas. In the present study we investigated if α 2-adrenergic/imidazoline and serotonergic inhibitory mechanisms interact to control NaCl and water intake. Male Holtzman rats with cannulas implanted simultaneously into the lateral ventricle (LV) and bilaterally into the LPBN were used. The ingestion of 0.3 M NaCl and water was induced by treatment with the diuretic furosemide (10 mg/kg of body weight)+the angiotensin converting enzyme inhibitor captopril (5 mg/kg) injected subcutaneously 1 h before the access of rats to water and 0.3 M NaCl. Intracerebroventricular (i.c.v.) injection of the α 2-adrenergic/imidazoline agonist clonidine (20 nmol/1 μl) almost abolished water (1.6±1.2, vs. vehicle: 7.5±2.2 ml/2 h) and 0.3 M NaCl intake (0.5±0.3, vs. vehicle: 2.2±0.8 ml/2 h). Similar effects were produced by bilateral injections of the 5HT 2a/2c serotonergic agonist 2,5-dimetoxy-4-iodoamphetamine (DOI, 5 μg/0.2 μl each site) into the LPBN on water (3.6±0.9 ml/2 h) and 0.3 M NaCl intake (0.4±0.2 ml/2 h). Injection of the α 2-adrenergic/imidazoline antagonist idazoxan (320 nmol) i.c.v. completely blocked the effects of clonidine on water (8.4±1.5 ml/2 h) and NaCl intake (4.0±1.2 ml/2 h), but did not change the effects of LPBN injections of DOI on water (4.2±1.0 ml/2 h) and NaCl intake (0.7±0.2 ml/2 h). Bilateral injections of methysergide (4 μg/0.2 μl each site) into the LPBN increased 0.3 M NaCl intake (6.4±1.9 ml/2 h), not water intake. The inhibitory effect of i.c.v. clonidine on water and 0.3 M NaCl was still present after injections of methysergide into the LPBN (1.5±0.8 and 1.7±1.4 ml/2 h, respectively). The results show that the inhibitory effects of the activation of α 2-adrenergic/imidazoline receptors in the forebrain are still present after blockade of the LPBN serotonergic mechanisms and vice versa for the activation of serotonergic mechanisms of the LPBN. Therefore, each system may act independently to inhibit NaCl and water intake.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>12426052</pmid><doi>10.1016/S0006-8993(02)03486-8</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-8993
ispartof Brain research, 2002-11, Vol.956 (1), p.103-109
issn 0006-8993
1872-6240
language eng
recordid cdi_proquest_miscellaneous_72669044
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects Amphetamines - administration & dosage
Amphetamines - pharmacology
Angiotensin II
Angiotensin-Converting Enzyme Inhibitors - pharmacology
Animals
Biological and medical sciences
Captopril - pharmacology
Cerebellar Nuclei - drug effects
Cerebellar Nuclei - physiology
Clonidine
Clonidine - administration & dosage
Clonidine - pharmacology
Diuretics - pharmacology
Drinking - drug effects
Drinking - physiology
Drinking Behavior - drug effects
Drinking Behavior - physiology
Feeding. Feeding behavior
Fundamental and applied biological sciences. Psychology
Furosemide - pharmacology
Idazoxan - administration & dosage
Idazoxan - pharmacology
Imidazoline Receptors
Injections, Intraventricular
Male
Methysergide - administration & dosage
Methysergide - pharmacology
Rats
Rats, Sprague-Dawley
Receptors, Drug - physiology
Receptors, Serotonin - physiology
Serotonin
Serotonin Antagonists - administration & dosage
Serotonin Antagonists - pharmacology
Serotonin Receptor Agonists - administration & dosage
Serotonin Receptor Agonists - pharmacology
Sodium appetite
Sodium Chloride, Dietary
Vertebrates: anatomy and physiology, studies on body, several organs or systems
α 2-Adrenergic receptor
title Central serotonergic and adrenergic/imidazoline inhibitory mechanisms on sodium and water intake
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T06%3A02%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Central%20serotonergic%20and%20adrenergic/imidazoline%20inhibitory%20mechanisms%20on%20sodium%20and%20water%20intake&rft.jtitle=Brain%20research&rft.au=Oliveira%20Margatho,%20Lisandra&rft.date=2002-11-22&rft.volume=956&rft.issue=1&rft.spage=103&rft.epage=109&rft.pages=103-109&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/S0006-8993(02)03486-8&rft_dat=%3Cproquest_cross%3E18616028%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18616028&rft_id=info:pmid/12426052&rft_els_id=S0006899302034868&rfr_iscdi=true